Home › Companies › Amicogen

Amicogen

아미코젠 · 092040 · KOSDAQ
Filings, last 12 months
73
Supply contracts
0
Insider reports
6
Share & bond issues
2

At a glance

Amicogen filed 73 disclosures in the last 12 months, including 6 insider, 2 issuance and 1 5% holder. The most recent key filing was on Sep 3.

Revenue for 2025 was ₩42B, down 75.8% on 2024. It made an operating loss of ₩17.1B. Debt was 142% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩25.7B and operating loss of ₩4.5B.

The 2025 annual report lists 228 employees with an average tenure of 6.3 years and average pay of ₩49.7M, #1461 of 1,829 listed companies by average pay. Its 7 directors and auditors were paid ₩94M each on average. It paid no cash dividend for 2025. 마가파트너스투자조합 and related parties held 4.59% at year end.

From the 2025 annual report

Employees
228
Average pay
₩49.7M
Average tenure
6.3 yrs
Avg. director pay
₩94M

Staff: 228 (163 men, 65 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩11.4B. Directors and auditors: 7, paid ₩661M in total.

No cash dividend was paid for 2025.

Largest shareholder

마가파트너스투자조합 holds 3.90%; with 4 related parties the group holds 4.59% of common shares at year end (from 0.45% at the start of the year).

Auditor: 삼덕회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary

2023
Revenue ₩160B
Op. profit ₩2.1B
Debt/equity 113%
2024
Revenue ₩174B
Op. profit -₩7.1B
Debt/equity 139%
2025
Revenue ₩42B
Op. profit -₩17.1B
Debt/equity 142%
2026 H1
Revenue ₩25.7B
Op. profit -₩4.5B
Debt/equity 66%
RevenueOperating profitOperating lossConsolidated where available · from periodic reports

Key filings

8/4IssuanceAmendedRights offering
7/28IssuanceAmendedRights offering
7/15IssuanceAmendedRights offering
6/23IssuanceAmendedRights offering
6/22IssuanceRights offering
2/4IssuanceAmendedRights offering
1/20IssuanceAmendedRights offering
12/19IssuanceRights offering

Other filings

Links open the original filing on DART, in Korean.